Nonribosomal peptide synthetases (NRPSs) are large multimodular proteins that produce a huge variety of bioactive nonribosomal peptide (NRP) natural products, including small cyclic dipeptides such as the 2,5-diketopiperazines ([@r1]) and the pyrazinones ([@r2][@r3]--[@r4]). NRP biosynthesis occurs via a thiotemplate mechanism, with each module responsible for the colinear incorporation of a single amino acid substrate into the growing peptide chain ([@r5][@r6]--[@r7]). Each module contains an adenylylation (A) domain, which binds and activates a specific amino acid substrate using adenosine 5′-triphosphate, and a thiolation (T) domain with a 4′-phosphopantetheinyl cofactor to which the activated aminoacyl substrate is tethered via a thioester bond. Modules downstream of the N-terminal "initiation" module also begin with a condensation (C) domain, which catalyzes peptide bond formation between adjacent thiotethered aminoacyl or peptidyl intermediates, and all modules may optionally contain one or more accessorizing domains that modify the aminoacyl intermediate, such as the *N*-methyltransferase (M) domain. Most NRPSs end with a termination domain, such as a thioesterase or reductase (R) domain, which catalyzes release of the mature peptidyl chain ([@r8]).

Peramine (**1a**; [Fig. 1](#fig01){ref-type="fig"}) is a pyrrolopyrazine-1-one metabolite (PPZ-1-one) synthesized by fungi of genus *Epichloë* ([@r9]), which are symbiotic endophytes of cool-season grasses ([@r10]). *Epichloë* spp. produce a range of bioactive secondary metabolites that protect their grass hosts against herbivory ([@r10]), and production of **1a** is agriculturally desirable due to the protection it provides against the pastoral pest insect *Listronotus bonariensis* (Argentine stem weevil) ([@r9], [@r11], [@r12]). Biosynthesis of **1a** is catalyzed by the 2-module NRPS "PpzA-1," which has the domain structure A~1~-T~1~-C~2~-A~2~-M~2~-T~2~-R~2~, where numbers indicate the module to which each domain belongs ([@r2]). PpzA-1 also has a partial C domain at its N terminus that is thought to be an evolutionary relic required to maintain A-domain stability ([@r13]). The first module of PpzA-1 is thought to incorporate a pyrrolidine-containing amino acid substrate, while the second module incorporates and *N*-methylates arginine (Arg). A peptide bond is then formed between these aminoacyl substrates, and the resulting dipeptidyl thioester is reductively released by the R~2~ domain as a dipeptide aldehyde intermediate that is then thought to undergo spontaneous cyclization, rearrangement, and oxidation reactions to form **1a**.

![Functionally divergent regions of PpzA-1 and PpzA-2 proteins. (*A*) Sliding-window analysis (width = 100, step = 50) of protein sequence conservation across an alignment of Efe_PpzA-1 and Efe_PpzA-2 protein sequences. The Efe_PpzA-1 protein map is annotated to show approximate domain boundaries and the A~1~-domain substrate binding region (A~1~-SBR). The positions of substitutions that are both conserved among PpzA-2 proteins and unique to PpzA-2 proteins are annotated on the Efe_PpzA-2 protein map with black pins. Gray pins indicate residues which are always substituted in PpzA-2 proteins relative to PpzA-1 proteins but whose identities are not fully conserved among PpzA-2 proteins. (*B*) A~1~- and A~2~-domain NRPS code residues for representative PpzA-1 and PpzA-2 protein sequences. Residues that differ from *Epichloë* spp. PpzA-1 codes are highlighted in red. (*C*) Structure of peramine (**1a**).](pnas.1913080116fig01){#fig01}

This study focuses on allelic variants of *ppzA* that contain a transposable element insertion into the 3′ end of the gene, resulting in deletion of all sequence encoding the C-terminal R~2~ domain ([@r14][@r15]--[@r16]). While initially assumed to be pseudogenes, these truncated "*ppzA-2*" alleles were subsequently found to be widely distributed across multiple *Epichloë* spp. ([@r14]) and are still expressed at levels comparable to *ppzA-1* ([@r17], [@r18]). The *ppzA-1* and *ppzA-2* alleles also exhibit transspecies polymorphisms (TSP), suggesting that balancing selection has maintained both alleles since the emergence of *ppzA-2* in a common ancestor of most *Epichloë* spp. ([@r14]). We therefore hypothesized that *ppzA-2* alleles may encode functional NRPSs with novel biosynthetic activities. As bioprotective *Epichloë* secondary metabolism genes such as *ppzA* are typically only expressed by *Epichloë* spp. *in planta* ([@r2], [@r19]), we use a heterologous expression system to identify the PPZ metabolites produced by different PpzA variants. We also investigate the biosynthetic mechanisms underpinning PPZ biosynthesis and demonstrate how recombination between different *ppzA* alleles has driven PPZ biosynthetic diversity. Note that while the peramine synthetase-encoding gene was originally abbreviated as "*perA*" ([@r2]), we suggest a modification to "*ppzA*" to better reflect the class of metabolites produced, with allele *ppzA-1* being synonymous with *perA*.

Results {#s1}
=======

Identifying Divergent Regions in PpzA-2 Proteins. {#s2}
-------------------------------------------------

Although PpzA-2 proteins lack the C-terminal R~2~ domain found in PpzA-1, the domain structures of PpzA-1 and PpzA-2 proteins are otherwise identical. Sliding-window analysis showed that conservation between *Epichloë festucae* PpzA-1 (Efe_PpzA-1) and PpzA-2 (Efe_PpzA-2) proteins approaches 100% sequence identity in many regions ([Fig. 1*A*](#fig01){ref-type="fig"}). However, discrete regions within the A~1~, C~2~, M~2~, and T~2~ domains exhibit increased divergence, and substitutions that are both conserved among and unique to PpzA-2 proteins (PpzA-2--conserved substitutions) are exclusively located within these divergent regions ([Fig. 1*A*](#fig01){ref-type="fig"} and [*SI Appendix*, Figs. S1--S4](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)). Efe_PpzA-2 sequence divergence within the A~1~ domain primarily affected the substrate-binding region (SBR), which is located between conserved A-domain motifs A4 and A5 ([*SI Appendix*, Fig. S1](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)) ([@r20]). This SBR contains 9 of the 10 "NRPS code" residues, which are the primary determinants of A-domain substrate specificity ([@r21]). The NRPS code residues of PpzA-1 A~1~ domains are absolutely conserved across all *Epichloë* spp.; however, 2 of these residues are always substituted in PpzA-2 proteins, and additional substitutions are observed in PpzA-2 proteins from *Epichloë bromicola* and *Epichloë typhina* strains ([Fig. 1*B*](#fig01){ref-type="fig"} and [*SI Appendix*, Fig. S1](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)). This lack of NRPS code conservation suggests that the A~1~ domains from PpzA-1 and PpzA-2 proteins may recognize different amino acid substrates.

Recombinational Shuffling Has Generated ppzA Allelic Diversity. {#s3}
---------------------------------------------------------------

Sliding-window phylogenetic comparison between different *ppzA* alleles indicated that the *Efe_ppzA-2* is actually a chimeric allele resulting from several recombinational cross-over events between ancestral *ppzA-1* and *ppzA-2* sequences ([Fig. 2*A*](#fig02){ref-type="fig"}). Approximately 25% of *Efe_ppzA-2*, including the A~1~ SBR, the 5′ end of the M~2~ domain, the T~2~ domain, and a small part of the A~2~-encoding region, appears to be inherited from an ancestral *ppzA-2* allele. The remaining 75% of *Efe_ppzA-2*, including the T~1~ and C~2~ domains, the majority of the A~1~ and A~2~ domains, and the 3′ end of the M~2~ domain, appears to descend from an ancestral *ppzA-1* allele ([Fig. 2*A*](#fig02){ref-type="fig"}). Very similar patterns of recombination were observed in *ppzA-2* alleles from *E. bromicola* (*Ebr_ppzA-2*); however, the *ppzA-1*--derived regions of *Ebr_ppzA-2* and *Efe_ppzA-2* alleles still grouped with extant *Ebr_ppzA-1* and *Efe_ppzA-1* sequences, respectively ([*SI Appendix*, Fig. S5](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)). This phylogeny therefore supports a convergent evolution model where *Ebr_ppzA-2* and *Efe_ppzA-2* were generated by independent yet equivalent recombination events that occurred after divergence of the *E. bromicola* and *E. festucae* lineages. No evidence of widespread recombination between *ppzA* alleles was observed within the *E. typhina* clade ([*SI Appendix*, Fig. S5](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)).

![Recombination between *ppzA* alleles generated additional diversity. (*A*) Sliding-window comparison of listed alleles to consensus sequences for *Ety_ppzA-1*, *Ety_ppzA-2*, *Efe_ppzA-1* (for *Efe_ppzA_2*, *Eba_ppzA-3*, and *Esi_ppzA-4*), or *Ebr_ppzA-1* (for *Ebr_ppzA-2* and *Ebr_ppzA-3*) using DualBrothers 1.1.5 ([@r52]) to identify spatial variations in phylogenetic topology (200-bp window, 50-bp step). Graph lines are slightly offset on the vertical axis to aid visual clarity. (*B*) Proposed order of ancestral meiotic recombination events between *ppzA* alleles in the *E. festucae* clade lineage, where *E. baconii* is defined as an *E. festucae* clade member. Ancestral and recombination-derived *ppzA-2* alleles are differentiated as *ppzA-2*^*A*^ and *ppzA-2*^*R*^, respectively.](pnas.1913080116fig02){#fig02}

Some *ppzA* alleles from *Epichloë baconii*, *E. bromicola*, and *E. festucae* isolates contained the same 3′ deletion found in *ppzA-2* alleles yet exhibited recombination patterns that were different from their *ppzA-2* counterparts and were therefore defined as "*ppzA-3*" and "*ppzA-4*" alleles ([Fig. 2](#fig02){ref-type="fig"}). The *ppzA-3* allele was identified from some *E. bromicola* and *E. baconii* strains and differs from its *ppzA-2* counterparts in that it retains a *ppzA-1*--type A~1~ SBR-encoding region ([Fig. 2*A*](#fig02){ref-type="fig"}). Phylogenetic sequence analysis suggests that these *Ebr_ppzA-3* and *Eba_ppzA-3* alleles represent intermediates during the evolution of *Ebr_ppzA-2* and *Efe_ppzA-2*, respectively ([Fig. 2*B*](#fig02){ref-type="fig"} and [*SI Appendix*, Fig. S5](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)); however, both alleles have also been retained within their respective host populations. The *ppzA-4* allele was only identified in *Epichloë siegelii*, which is an asexual allopolyploid hybrid species of *E. festucae* and *E. bromicola* ([@r22]). This *Esi_ppzA-4* allele is from the *E. festucae*-derived portion of the *E. siegelii* genome and appears to be an *Efe_ppzA-2* sequence that underwent an additional recombination event that replaced most of the M~2~-encoding region with sequence from an *Efe_ppzA-1* donor ([Fig. 2 *A* and *B*](#fig02){ref-type="fig"} and [*SI Appendix*, Fig. S5](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)). Because *E. siegelii* is asexual and lacks a suitable *Efe_ppzA-1* donor sequence, this additional recombination event likely predates the emergence of *E. siegelii*, although an equivalent *ppzA-4* allele has not been observed in any *E. festucae* isolates to date.

The Truncated Allele *ppzA-2* Encodes a Pyrrolopyrazine-1,4-Dione Synthetase. {#s4}
-----------------------------------------------------------------------------

The fungus *Penicillium paxilli* strain PN2013 was utilized as a naive heterologous expression host to identify the metabolite products of the enzymes encoded by different *ppzA* alleles, with **1a**-producing PN2013/*Efe_ppzA-1* control strains obtained from a previous study ([@r23]). As expected, PN2013 transformants expressing *Efe_ppzA-2* from *E. festucae* strain E189 or *Ety_ppzA-2* from *E. typhina* subsp. *poae* strain E1022 did not produce **1a** ([*SI Appendix*, Table S1](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)); however, metabolomic analysis identified a 254.16 *m*/*z* metabolite exclusively produced by these *ppzA-2*--expressing strains ([*SI Appendix*, *Supplementary Note*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)). Liquid chromatography-coupled tandem mass spectrometry comparison to a synthetic standard and NMR analysis of the purified natural product determined that this metabolite was the PPZ-1,4-dione molecule cyclo([l]{.smallcaps}-Pro, [l]{.smallcaps}-Arg) (**2a**) ([Fig. 3 *A* and *B*](#fig03){ref-type="fig"} and [*SI Appendix*, *Supplementary Note*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)). Analysis of extracts from grass material confirmed that **2a** was present in all samples infected with *ppzA-2-*genotype *Epichloë* isolates, whereas **2a** was not observed in any samples infected with *ppzA-1-*genotype *Epichloë* isolates or in uninfected plants ([Table 1](#t01){ref-type="table"}). The *Efe_ppzA-2* gene was deleted in *E. festucae* strain E189 ([*SI Appendix*, Fig. S6](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)), and loss of **2a** was confirmed in grass samples infected with these ∆*Efe_ppzA-2* mutants ([Fig. 3*C*](#fig03){ref-type="fig"} and [*SI Appendix*, Table S2](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)).

![Identification and characterization of PPZ-1,4-diones synthesized by PpzA-2 proteins. (*A*) Polymorphic structures showing all PPZ metabolites described in this study. (*B*) Comparison of MS^2^ spectra generated at 35% normalized collision energy for a synthetic **2a** standard vs. a 254.16 *m*/*z* metabolite extracted from *E. typhina*-infected plant material and PN2013/*Ety_ppzA-2* mycelia. (*C*) Concentration of **2a** in blade (BLD) or pseudostem (PST) tissue from 2 different grass hosts infected with wild-type *E. festucae* E189 or 1 of 2 ∆*ppzA-2* mutants. Error bars show the SEM; "nd" indicates where **2a** was not detected in a sample (limit of detection 0.05 µg/g). (*D*) Concentration of metabolites **2a** and **2b** in extracts from cultures of *P. paxilli* strains that express the PpzA proteins shown to the left of the image. Protein maps are annotated with domain boundaries, and synthetic hybrid proteins are colored to indicate the natural PpzA protein from which each region is derived. Concentrations are averaged across at least 3 independent transformants for each *ppzA* expression construct, with the SEM shown in parentheses. Metabolites that were not detected are annotated "nd" (limit of detection 0.05 µg/g). Colored bars illustrate the relative between-sample concentration for each metabolite. Concentrations for **2b** are estimates based on the response factor of synthetic **2a**. \*\**P* \< 0.01 and \*\*\**P* \< 0.001.](pnas.1913080116fig03){#fig03}

###### 

PPZ profile of grasses infected with representative *Epichloë* strains[\*](#tfn1){ref-type="table-fn"}

                                                                                    PPZ concentration[^†^](#tfn2){ref-type="table-fn"}, µg/g                                   
  ---------- ---------------------------- ---------- ------------------------------ ---------------------------------------------------------- ----- ----- ------ ----- ------ -----
  *ppzA-1*   *E. bromicola*               NFe1       *Hordeum bogdanii*             26.4                                                       0.2   nd    nd     nd    1.0    0.4
  *ppzA-1*   *E. festucae* var. *lolii*   AR5        *Lolium perenne*               19.1                                                       nd    nd    nd     nd    6.0    nd
  *ppzA-1*   *E. typhina*                 E8         *Lolium perenne*               347                                                        0.3   LOQ   4.3    4.0   58.3   nd
  *ppzA-1*   *E. typhina* ssp. *poae*     NFe76      *Bromus laevipes*              101                                                        LOQ   nd    nd     nd    18.5   nd
  *ppzA-2*   *E. festucae*                E189       *Festuca rubra* ssp. *rubra*   nd                                                         nd    nd    19.3   1.2   nd     nd
  *ppzA-2*   *E. typhina*                 AL1218     *Dactylis glomerata*           nd                                                         nd    nd    699    nd    nd     0.6
  *ppzA-2*   *E. typhina* ssp. *poae*     AL9921/1   *Poa nemoralis*                nd                                                         nd    nd    32.9   nd    nd     nd
  *ppzA-3*   *E. baconii*                 E424       *Agrostis tenuis*              nd                                                         nd    nd    nd     nd    nd     0.4
  *ppzA-3*   *E. bromicola*               NFe7       *Hordeum brevisbulatum*        nd                                                         nd    nd    nd     nd    nd     9.6
  *ppzA-4*   *E. siegelii*                e915       *Festuca arundinacea*          nd                                                         nd    nd    nd     515   0.7    nd
  *ppzA-5*   *E. uncinata*                e167       *Festuca pratensis*            nd                                                         nd    nd    nd     nd    2.5    nd
  N/A        uninfected                   N/A        *Bromus laevipes*              nd                                                         nd    nd    nd     nd    nd     nd

Results from additional associations and some replicates are in [*SI Appendix*, Table S2](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental).

Metabolites that were not detected are annotated "nd" (limit of detection 0.05 µg/g). LOQ indicates detection of a metabolite at a concentration below the limit of quantitation (0.2 µg/g).

As determined by sequence analysis.

Approximate concentration based on response factor of synthetic **1a**.

Approximate concentration based on response factor of synthetic **2a**.

Mean production of **2a** was 10-fold higher in PN2013/*Ety_ppzA-2* cultures compared to PN2013/*Efe_ppzA-2* cultures (*P* = 0.038; [Fig. 3*D*](#fig03){ref-type="fig"}), and plant material infected with *Ety_ppzA-2*-genotype endophytes also exhibited the highest **2a** concentrations ([Table 1](#t01){ref-type="table"} and [*SI Appendix*, Table S3](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)), suggesting that Ety_PpzA-2 may be a more efficient **2a** synthetase. The absence of an Arg *N*-methyl group in the structure of **2a** ([Fig. 3*A*](#fig03){ref-type="fig"}) suggested that the PpzA-2--specific M~2~-domain substitutions may have eliminated *N*-methyltransferase activity ([Fig. 1*A*](#fig01){ref-type="fig"} and [*SI Appendix*, Fig. S3](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)). Targeted analysis revealed that the *N*-methylated PPZ-1,4-dione cyclo(Pro, meArg) (**2b**; [Fig. 3*A*](#fig03){ref-type="fig"}) was also produced by *Efe_ppzA-2* strains, but not by *Ety_ppzA-2* strains ([Fig. 3*D*](#fig03){ref-type="fig"} and [*SI Appendix*, *Supplementary Note*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)). Synthetic allele *ppzA-S1* was generated by replacing the M~2~-encoding sequence of *Efe_ppzA-2* with its *Efe_ppzA-1* equivalent to investigate whether the production of **2a** by Efe_PpzA-2 was due to reduced *N*-methyltransferase activity. This abolished production of **2a** and massively increased production of **2b** ([Fig. 3*D*](#fig03){ref-type="fig"}), demonstrating that *N*-methyltransferase activity has been reduced in Efe_PpzA-2 by substitutions within the M~2~ domain. Additional lineage-specific substitutions may explain the complete loss of M~2~-domain function in Ety_PpzA-2 ([*SI Appendix*, Fig. S3](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)).

PpzA-1 and PpzA-2 Proteins Bind Different A~1~-Domain Substrates. {#s5}
-----------------------------------------------------------------

Structural conservation between **1a** and **2a-b** ([Fig. 3*A*](#fig03){ref-type="fig"}) suggests that the A~2~ domains of PpzA-1 and PpzA-2 proteins share [l]{.smallcaps}-Arg as substrate, and this is supported by the absolute conservation of the substrate-defining NRPS code between A~2~ domains from all PpzA proteins ([Fig. 1*B*](#fig01){ref-type="fig"}). The PpzA-2 A~1~-domain substrate can similarly be inferred as [l]{.smallcaps}-Pro from the structures of **2a-b**; however, the spontaneous pyrrolidine oxidation step proposed during **1a** biosynthesis ([@r2]) and different NRPS codes exhibited by A~1~ domains from PpzA-1 vs. PpzA-2 proteins ([Fig. 1*B*](#fig01){ref-type="fig"}) mean that the PpzA-1 A~1~-domain substrate cannot be determined with certainty. Identification of the cognate PpzA-1 A~1~-domain substrate was therefore attempted by feeding several candidate amino acids to PN2013/*Efe_ppzA-1* cultures to assess their effects on **1a** production. Of these, only *trans*-4-hydroxy-[l]{.smallcaps}-proline (T4HP) and *cis*-4-hydroxy-[d]{.smallcaps}-proline (C4HP) had a substantial impact, with each of these 4-hydroxy-proline (4HP) stereoisomers increasing **1a** production 50-fold relative to water-fed controls ([Table 2](#t02){ref-type="table"}). Modeling the PpzA-1 A~1~-domain structure places the NRPS code residues Thr500 and Glu521 in a position that would enable hydrogen bonding interactions with the pyrrolidine-hydroxy group of T4HP and/or C4HP ([*SI Appendix*, Fig. S7](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)). In contrast, Thr500 is substituted for Ser and Glu521 is substituted for Gly/Ala in PpzA-2 proteins, presumably altering the binding pocket shape and charged microenvironment to favor Pro as substrate. Additional supplementation of PN2013/*Efe_ppzA-1* cultures with [l]{.smallcaps}-Arg did not further increase **1a** production over 4HP feeding alone ([Table 2](#t02){ref-type="table"}), indicating that [l]{.smallcaps}-Arg availability was not limiting **1a** production. T4HP feeding was therefore used in subsequent experiments to improve production of 4HP-derived metabolites.

###### 

Substrate feeding effects on PPZ production

                                                  PPZ concentration[\*](#tfn6){ref-type="table-fn"}, µg/g                                 
  -------------- -------------------------------- --------------------------------------------------------- ----- ---- ------ ----- ----- -----
  *Efe_ppzA-1*   CD + H~2~O                       0.3                                                       nd    nd   nd     nd    nd    nd
  *Efe_ppzA-1*   CD + [l]{.smallcaps}-Glu         LOQ                                                       nd    nd   nd     nd    nd    nd
  *Efe_ppzA-1*   CD + [l]{.smallcaps}-Pro         1.0                                                       nd    nd   nd     2.4   nd    nd
  *Efe_ppzA-1*   CD + P2C                         0.5                                                       nd    nd   nd     nd    nd    nd
  *Efe_ppzA-1*   CD + C4HP                        21.1                                                      LOQ   nd   nd     nd    3.6   nd
  *Efe_ppzA-1*   CD + T4HP                        20.8                                                      LOQ   nd   nd     nd    4.7   nd
  *Efe_ppzA-1*   CD + T4HP, [l]{.smallcaps}-Arg   15.3                                                      LOQ   nd   nd     nd    3.4   nd
  *Efe_ppzA-2*   CD + H~2~O                       NT                                                        NT    NT   28.6   8.0   nd    nd
  *Efe_ppzA-2*   CD + [l]{.smallcaps}-Pro         NT                                                        NT    NT   23.0   6.9   nd    nd
  *Efe_ppzA-2*   CD + P2C                         NT                                                        NT    NT   26.5   8.3   nd    nd
  *Efe_ppzA-2*   CD + T4HP                        NT                                                        NT    NT   18.3   3.4   1.2   3.4
  neg. ctrl      CD + [l]{.smallcaps}-Pro         nd                                                        nd    nd   nd     nd    nd    nd
  neg. ctrl      CD + T4HP                        nd                                                        nd    nd   nd     nd    nd    nd

PPZ concentrations are averaged across cultures of 3 independent *P. paxilli* strains transformed with *Efe_ppzA-1*, *Efe_ppzA-2*, or empty pRS426 vector (negative control). Metabolites that were not detected are annotated "nd" (limit of detection 0.05 µg/g). LOQ indicates detection of a metabolite at a concentration below the limit of quantitation (0.2 µg/g). NT, not tested.

Cultures were grown in 50 mL Czapek Dox liquid medium under standard conditions with feeding of 2.4 × 10^−4^ mol each substrate after 4 and 5 d growth.

Approximate concentration based on response factor of synthetic **1a**.

Approximate concentration based on response factor of synthetic **2a**.

PN2013/*Efe_ppzA-1* cultures fed with 4HP also produced the PPZ-1,4-dione cyclo(4HP, meArg) (**2c**; [Fig. 3*A*](#fig03){ref-type="fig"} and [*SI Appendix*, *Supplementary Note*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)), which contains a hydroxy group attached to the pyrrolidine ring. Although PpzA-1 had previously only been reported to synthesize **1a** ([@r2]), **2c** was subsequently identified in all *ppzA-1*-genotype samples with sufficiently high **1a** concentrations. The hydrogenated PPZ-1-one **1b** ([Fig. 3*A*](#fig03){ref-type="fig"} and [*SI Appendix*, *Supplementary Note*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)), which is likely an intermediate that exists in weak equilibrium with **1a**, was also detected in 4HP-fed cultures ([Table 2](#t02){ref-type="table"}). Additionally, feeding PN2013/*Efe_ppzA-1* cultures with [l]{.smallcaps}-Pro induced production of the PPZ-1,4-dione **2b** ([Table 2](#t02){ref-type="table"}), indicating that the Efe_PpzA-1 A~1~ domain exhibits some weak specificity toward this substrate. Feeding PN2013/*Efe_ppzA-2* cultures with T4HP similarly induced production of the hydroxylated PPZ-1,4-diones **2c** and cyclo(4HP, Pro) (**2d**; [Fig. 3*A*](#fig03){ref-type="fig"} and [*SI Appendix*, *Supplementary Note*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)), indicating the Efe_PpzA-2 A~1~ domain retains residual specificity toward 4HP ([Table 2](#t02){ref-type="table"}). Unlike production of **1a** by PN2013/*Efe_ppzA-1* cultures, PN2013*/Efe_ppzA-2* cultures did not appear to be substrate-limited for production of **2a** and **2b**, as feeding [l]{.smallcaps}-Pro and [l]{.smallcaps}-Arg did not dramatically increase **2a** concentrations (41.3 µg/g with [l]{.smallcaps}-Pro/[l]{.smallcaps}-Arg feeding vs. 26.5 µg/g water-fed control). Collectively, these results show that 4HP is likely the substrate of the PpzA-1 A~1~ domain, and that PpzA-1 can synthesize both PPZ-1-one and PPZ-1,4-dione products.

Truncated Alleles *ppzA-3* and *ppzA-4* also Encode Functionally Distinct PPZ-1,4-Dione Synthetases. {#s6}
----------------------------------------------------------------------------------------------------

As the A~1~ domains of PpzA-3 proteins retain PpzA-1--like NRPS codes ([*SI Appendix*, Fig. S1](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)), these were predicted to bind 4HP substrate. Expression of *Eba_ppzA-3* from *E. baconii* strain As6 in *P. paxilli* induced production of the hydroxylated PPZ-1,4-diones **2d** and **2c** ([Fig. 4](#fig04){ref-type="fig"}). Replacement of the A~1~ SBR-encoding region of *Efe_ppzA-2* with the equivalent sequence from *Efe_ppzA-1* was used to generate *ppzA-S2*, which is a synthetic analog of *ppzA-3*. Expression of *ppzA-S2* also induced production of **2c** and **2d** in *P. paxilli* ([Fig. 4](#fig04){ref-type="fig"}). Analysis of *Epichloë*-infected plant material also showed that **2d** was exclusive to samples infected with *ppzA-3*-genotype *E. baconii* or *E. bromicola* strains ([Table 1](#t01){ref-type="table"}), although concentrations were much higher in the *E. bromicola*-infected material.

![PPZ synthesis profiles of different PpzA proteins. Each row shows the PPZ profile of T4HP-fed *P. paxilli* strains expressing each of the proteins shown to the left of the image. Protein maps are annotated with domain boundaries, and synthetic hybrid proteins are colored to indicate the natural PpzA protein from which each region is derived. Concentrations are averaged across at least 3 independent transformants for each *ppzA* expression construct, with the SEM shown in parentheses. Where PPZ production was not observed for all strains, the number (n) of strains used to generate the listed concentration is shown instead of the SE. Metabolites that were not detected are annotated "nd" (limit of detection 0.05 µg/g). LOQ indicates detection of a metabolite at a concentration below the limit of quantitation (0.2 µg/g). NT = not tested. The **1a** concentrations for a small subset of these analyses, which are indicated by an asterisk (\*), were determined using slightly less sensitive method (limit of detection 0.1 µg/g). Colored bars illustrate the relative between-sample concentration for each metabolite. The concentrations listed for **1b--c** are estimates based on the response factor of synthetic **1a**, while the concentrations listed for **2b**--**d** are estimates based on the response factor of synthetic **2a**.](pnas.1913080116fig04){#fig04}

Unlike PpzA-3, the A~1~-domain NRPS code of Esi_PpzA-4 is identical to that of Efe_PpzA-2 ([Fig. 2](#fig02){ref-type="fig"} and [*SI Appendix*, Fig. S1](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)) and was therefore predicted to bind [l]{.smallcaps}-Pro substrate. However, while *Esi_ppzA-4* is derived from *Efe_ppzA-2*, much of the M~2~-domain-encoding region of *Esi_ppzA-4* has been replaced with sequence from an *Efe_ppzA-1* donor ([Fig. 2](#fig02){ref-type="fig"} and [*SI Appendix*, Fig. S3](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)). This suggested that Esi_PpzA-4 may be a dedicated **2b** synthetase, as much of the weakly functional Efe_PpzA-2 M~2~-domain was replaced. This functionality was confirmed by analysis of *Epichloë*-infected plant material, which showed that high concentrations of **2b** were exclusive to *E. siegelii*-infected samples ([Table 1](#t01){ref-type="table"} and [*SI Appendix*, Table S3](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)). Furthermore, the synthetic allele *ppzA-S1* can be considered an analog of *Esi_ppzA-4*, and PpzA-S1 was also shown to be a dedicated **2b** synthetase ([Fig. 3*D*](#fig03){ref-type="fig"}). However, unlike PpzA-S1, Esi_PpzA-4 retains all of the conserved PpzA-2--conserved substitutions located at the N-terminal end of the M~2~ domain ([Fig. 2](#fig02){ref-type="fig"} and [*SI Appendix*, Fig. S3](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)). Given that the M~2~ domain of Esi_PpzA-4 appears to be fully functional, this implies a causative role for one or both of the PpzA-2--conserved M~2~-domain substitutions that are replaced in Esi_PpzA-4 (D1935A and P2003A; [*SI Appendix*, Fig. S3](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)).

PPZ-1,4-Dione Synthesis Is Proposed to Occur through Nonenzymatic Dipeptidyl-Thioester Cyclization. {#s7}
---------------------------------------------------------------------------------------------------

In the absence of the R~2~ domain, it is conceivable that release of PPZ-1,4-diones from truncated PpzA variants could be catalyzed by separate protein, such as a type II thioesterase. However, candidate genes for this function are not found coclustered with any *ppzA* variant ([@r2], [@r16], [@r23]). Furthermore, expression of these truncated *ppzA* variants alone was sufficient to achieve PPZ-1,4-dione production in the naive host *P. paxilli* at levels comparable to **1a** production by PN2013/*Efe_ppzA-1* strains ([Figs. 3*D*](#fig03){ref-type="fig"} and [4](#fig04){ref-type="fig"} and [*SI Appendix*, Table S1](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)). Given that transcription of all *ppzA* variants in *P. paxilli* was controlled by identical regulatory sequences, this suggests that all PpzA variants have similar biosynthetic efficiencies. This would therefore require a hypothetical endogenous *P. paxilli* protein that can catalyze dipeptidyl release at a rate similar to the integrated R~2~ domain of PpzA-1, which seems unlikely. We therefore propose that PPZ-1,4-dione production by PpzA proteins occurs through a spontaneous nucleophilic substitution reaction where the dipeptidyl-thioester sulfur atom is replaced by the pyrrolidine nitrogen atom, releasing a product with a 2,5-diketopiperazine (DKP) core ([Fig. 5](#fig05){ref-type="fig"}). This mechanism is equivalent to the pathway proposed by Stachelhaus et al. ([@r24]) for biosynthesis of the DKP cyclo(Phe, Pro) by an artificially truncated 2-module variant of the gramicidin synthetase NRPS complex and would not require a termination domain.

![Proposed PPZ biosynthetic pathways. Predicted reactions are shown after amino acid substrates have been selected, activated, and thio-tethered. Hatched shading is used to indicate the noncatalytic N-terminal partial C domain ([@r13]) and the weakly or nonfunctional PpzA-2 M~2~-domain. Residual M~2~-domain activity means that some PpzA-2 proteins produce both **2a** and **2b**. T4HP is shown as the A~1~-domain substrate for PpzA-1 and PpzA-3, but feeding experiments suggest this may be replaceable with C4HP. Biosynthesis of **2d** by PpzA-3 is equivalent to biosynthesis of **2a** by PpzA-2, except the [l]{.smallcaps}-Pro substrate is replaced with 4HP. Biosynthesis of **2b** by PpzA-4 is equivalent to PpzA-2-catalyzed biosynthesis of **2a**, except the M~2~ domain of PpzA-4 is functional. In the absence of the R~2~ domain, PpzA-5 biosynthesis of **2c** occurs via the competing autocatalytic dipeptidyl release pathway shown in red for PpzA-1.](pnas.1913080116fig05){#fig05}

Interestingly, biosynthesis of the PPZ-1,4-diones **2b** and **2c** was also observed for PpzA-1 proteins ([Fig. 4](#fig04){ref-type="fig"}, [Table 2](#t02){ref-type="table"}, and [*SI Appendix*, Table S1](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)), including the PpzA-1 ortholog from the insect pathogen *Metarhizium rileyi*, which belongs to the same family (Clavicipitaceae) as the *Epichloë* genus. This suggests that nonenzymatic cyclization of the dipeptidyl-thioester intermediate is not a novel innovation of the truncated PpzA proteins. Rather, nonenzymatic cyclization appears to compete with R~2~-catalyzed reduction for dipeptidyl thioester release from PpzA-1, and both activities were likely present in PpzA-1 from the last common ancestor of the *Epichloë* and *Metarhizium* genera. The transposable element insertion observed in all *ppzA-2*, *ppzA-3*, and *ppzA-4* alleles could therefore have eliminated the competing reductive release pathway through deletion of the R~2~-encoding sequence, resulting in immediate subfunctionalization of the encoded PpzA protein into a dedicated PPZ-1,4-dione synthetase.

To investigate this hypothesis, synthetic allele *ppzA-S3* was generated by truncating *Efe_ppzA-1* to the same length as *Efe_ppzA-2*. This R~2~-domain deletion abolished production of **1a** but did not affect production of **2c** ([Fig. 4](#fig04){ref-type="fig"}). Exchanging the T~2~-encoding sequence of *ppzA-S3* for its *Efe_ppzA-2* equivalent did not further improve **2c** production (PpzA-S4; [Fig. 4](#fig04){ref-type="fig"}), nor did exchanging the *Efe_ppzA-2* T~2~-encoding sequence for its *Efe_ppzA-1* equivalent reduce production of **2a** (PpzA-S5; [Fig. 3*D*](#fig03){ref-type="fig"}). These results demonstrate that **2c** release from PpzA proteins occurs through an R~2~-independent mechanism, with R~2~-domain truncation resulting in immediate subfunctionalization of PpzA-1 into a dedicated **2c** synthetase. Furthermore, although PpzA-2--conserved substitutions were identified within the T~2~ domain ([Fig. 1](#fig01){ref-type="fig"} and [*SI Appendix*, Fig. S4](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)), these impart no specific contribution to the efficiency of DKP formation. It was also observed that the artificially truncated *ppzA-S3* allele is similar to 1 of the 2 *ppzA* alleles present in *Epichloë uncinata* strain e167, which is an asexual allopolyploid hybrid species of *E. bromicola* and *E. typhina* subsp. *poae* ([@r22], [@r25]). Both *E. uncinata* alleles were previously thought to be pseudogenes ([@r14]); however, the premature stop codon in the *E. typhina*-derived allele only affects translation of the R~2~ domain. We therefore predicted this "*Eun_ppzA-5*" allele may encode a **2c** synthetase analogous to PpzA-S3. Analysis of *Epichloë*-infected plant material confirmed that *E. uncinata*-infected material contains **2c**, and this was the only plant material tested that contained **2c** in the absence of **1a** ([Table 1](#t01){ref-type="table"}). These results support the hypothesis that Eun_PpzA-5 is a dedicated **2c** synthetase, meaning that subfunctionalization of PpzA-1 into a dedicated PPZ-1,4-dione synthetase appears to have occurred at least twice in the evolutionary history of *Epichloë*.

The rate of nonenzymatic dipeptidyl-thioester cyclization would depend on the strength of the attacking nitrogen nucleophile, and the pyrrolidine hydroxy group could reduce this nucleophilicity in 4HP relative to Pro. To investigate if nonenzymatic cyclization of Pro-meArg thioesters is more efficient than for 4HP-meArg thioesters, synthetic allele *ppzA-S6* was generated by PCR-induced mutagenesis of *Efe_ppzA-1* to replace 3 A~1~ SBR NRPS code residues of PpzA-1 with their Pro-binding PpzA-2 equivalents ([Fig. 1*B*](#fig01){ref-type="fig"} and [*SI Appendix*, Fig. S1](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)). This significantly reduced production of **1a** by PpzA-S6 relative to Efe_PpzA-1, and PN2013/*ppzA-S6* cultures instead produced substantial quantities of **2b** ([Fig. 4](#fig04){ref-type="fig"}). Levels of **1a** in PN2013/*ppzA-S6* cultures were also still strongly inducible through T4HP feeding ([*SI Appendix*, Table S1](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)), indicating that incomplete A~1~-domain binding specificity conversion rather than oxidation of a Pro-incorporating intermediate was the source of this residual **1a** biosynthesis. Furthermore, no metabolite corresponding to a hypothetical Pro-derived reduced analog of **1a** (C~12~H~21~N~5~O, 252.18 *m*/*z*) was detected in any PN2013/*ppzA-S6* samples. These results suggest that nonenzymatic cyclization of Pro-incorporating dipeptidyl thioesters occurs much more rapidly than R~2~-catalyzed reductive release from PpzA proteins. In contrast, nonenzymatic release of 4HP-incorporating dipeptidyl thioesters appears to be slower, allowing R~2~-catalyzed reductive release to dominate. However, an alternative hypothesis where Pro-incorporating dipeptidyl intermediates are incompetent as R~2~-domain substrates cannot be excluded.

Attempts to further reduce 4HP binding specificity were made by exchanging the A~1~ SBR-encoding region of *Efe_ppzA-1* for that of *Efe_ppzA-2* or *Ety_ppzA-2* to generate synthetic alleles *ppzA-S7* and *ppzA-S8*, respectively. However, concentrations of both **1a** and **2b** were significantly reduced in PN2013/*ppzA-S7* cultures, while PN2013/*ppzA-S8* cultures did not produce detectable levels of any product ([Fig. 4](#fig04){ref-type="fig"}), indicating these subdomain exchanges were detrimental to protein function. This suggests that targeted mutagenesis of NRPS code residues may be a superior strategy to subdomain swaps when attempting to modify binding specificity toward an amino acid that is closely related to the cognate substrate for that A domain.

Restoring 1a Biosynthesis to Efe_PpzA-2 Defines All Functionally Divergent Regions. {#s8}
-----------------------------------------------------------------------------------

We have shown that the Efe_PpzA-2 A~1~ SBR and M~2~ domains are functionally divergent compared to PpzA-1 proteins, and that the R~2~ domain is required for **1a** biosynthesis. However, it was not clear if all functionally divergent regions within Efe_PpzA-2 had been identified. To investigate this, synthetic hybrid alleles *ppzA-S9* through *ppzA-S12* were generated by iterative replacement of the divergent *Efe_ppzA-2* A~1~ SBR, C~2~-, M~2~-, and R~2~-encoding regions with their *Efe_ppzA-1* equivalents. These alleles were expressed in *P. paxilli* PN2013 and assayed for **1a** production. Replacement of the A~1~ SBR and R~2~-encoding sequences alone in PpzA-S9 did not result in synthesis of **1a** or **2c**, although small amounts of the nonmethylated analogs **1c** and **2d** were detected in some strains ([Fig. 4](#fig04){ref-type="fig"} and [*SI Appendix*, *Supplementary Note*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)). Equivalent results were observed when the divergent C~2~-encoding region was additionally replaced in PpzA-S10 ([Fig. 4](#fig04){ref-type="fig"}). Replacement of the A~1~ SBR, M~2~-, and R~2~-encoding sequences in PpzA-S11 resulted in low but consistent production of **1a** ([Fig. 4](#fig04){ref-type="fig"}), and the additional replacement of the divergent portion of the C~2~-encoding region in PpzA-S12 fully restored **1a** production to the same level as wild-type Efe_PpzA-1 ([Fig. 4](#fig04){ref-type="fig"}). This shows that most Efe_PpzA-2--derived regions in PpzA-S12 (55%) are functionally equivalent to their Efe_PpzA-1 counterparts, although the C~2~ domain may have functionally diverged. However, no PpzA-2--conserved substitutions are present within the C~2~ domain ([Fig. 1*A*](#fig01){ref-type="fig"}), and modeling the Efe_PpzA-1 and Efe_PpzA-2 C~2~-domain structures did not reveal any clustering of differential residues ([*SI Appendix*, Fig. S8](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental)). The cause of this apparent differentiation between Efe_PpzA-1 and Efe_PpzA-2 C~2~-domains therefore remains unclear.

Discussion {#s9}
==========

Fungi typically contain a large number of secondary metabolism gene clusters, each of which encodes proteins involved in biosynthesis of a specific class of natural products ([@r26]). Within-class natural product diversity is usually a function of gene gain or loss polymorphisms within these clusters ([@r27]), as has been well documented for *Epichloë* species ([@r16], [@r28]). It is understandable that the PPZ product diversity encoded by the orphaned *ppzA* gene in *Epichloë* spp. was thought to be restricted to **1a**, especially given that *PPZ* clusters containing *ppzA-1* orthologs alongside at least 6 accessory genes were recently identified in *Metarhizium* and *Cladonia* spp. ([@r23]). However, the results presented here show that allelic variants of a single NRPS can generate metabolite diversity comparable to many gene clusters, with 4 functionally distinct *ppzA* alleles described here in addition to the previously characterized *ppzA-1* ([@r2], [@r23]). Of these, the *ppzA-2*, *ppzA-3*, and *ppzA-4* alleles all derive from the same 3′ sequence deletion caused by a transposable element insertion ([@r14], [@r15], [@r18]), whereas *ppzA-5* contains a premature stop codon near the 3′ end of the gene ([@r14]). In the absence of the C-terminal R~2~ domain, these truncated PpzA proteins are proposed to utilize nonenzymatic dipeptidyl-thioester cyclization to release a range of DKP-containing PPZ-1,4-dione products. Functional divergence of some PpzA-2 domains relative to their PpzA-1 progenitors is also demonstrated; PpzA-2 A~1~ domains have evolved to bind [l]{.smallcaps}-Pro as substrate instead of 4HP, and PpzA-2 proteins produce nonmethylated products due to their weakly active or inactive M~2~ domains. Recombination between *ppzA* alleles is also shown to have further enhanced the PPZ diversity encoded by this locus.

Fungi are known to produce a huge variety of DKP metabolites ([@r29]), and previous studies have described a number of fungal NRPS pathways dedicated to DKP biosynthesis ([@r1], [@r30][@r31][@r32][@r33][@r34]--[@r35]). While the mechanism of DKP formation in many of these NRPS pathways has not yet been resolved, this could conceivably occur through nonenzymatic cyclization of the dipeptidyl thioester. However, spontaneous *trans* → *cis* isomerization of the dipeptidyl peptide bond would be required before cyclization could occur, which is usually suppressed by steric repulsions between consecutive C^α^-linked side chains ([@r36]). Gao et al. ([@r37]) demonstrated that fungal NRPSs can utilize a C-terminal condensation-like "C~T~" domain to catalyze peptidyl cyclization, and all of the dedicated DKP-synthesizing fungal NRPSs described to date terminate with a C-like domain that could conceivably catalyze DKP release ([@r1], [@r30][@r31][@r32][@r33][@r34]--[@r35]). Indeed, Baccile et al. ([@r38]) recently demonstrated that the 2-module NRPS GliP requires a C-terminal C~T~--T~3~ didomain to catalyze synthesis of the DKP cyclo(Phe, Ser), which is the first step in gliotoxin biosynthesis, and proposed that this is a general mechanism for DKP biosynthesis by fungal NRPSs. Nonenzymatic dipeptidyl cyclization has been observed for some larger NRPS systems when peptidyl chain elongation is stalled by downstream substrate starvation, incorrect substrate loading, or artificial protein truncation ([@r24], [@r39], [@r40]). Formation of these DKP side-products typically involves Xaa-Pro (Xaa = any amino acid) or *N*-methylated "tertiary" dipeptidyl intermediates, as the influence of a third *N*-linked carbon atom in these tertiary peptide bonds significantly reduces the energy differential between the *cis* and *trans* isomers. However, spontaneous *trans* → *cis* isomerization of tertiary dipeptidyl peptide bonds still appears to be considerably slower than other NRPS-catalyzed reactions ([@r41]). Biosynthesis of the PPZ-1,4-diones by PpzA proteins therefore presents an enigma, as **2a** and **2d** biosynthesis does not occur via a tertiary dipeptidyl intermediate. These biosynthetic pathways should therefore be severely bottlenecked by *trans* → *cis* isomerization, yet our results suggest that the efficiency of PpzA-2-catalyzed **2a** biosynthesis is comparable to that of PpzA-1--catalyzed **1a** biosynthesis. This suggests that PpzA proteins are able to predispose the dipeptidyl thioester toward the *cis* conformation, for example by utilizing a C~2~ domain that specifically catalyzes *cis* peptide bond formation. While such a mechanism would obviously benefit PPZ-1,4-dione biosynthesis by removing the peptide isomerization bottleneck, it could also ensure that reductively released dipeptide-aldehyde intermediates are rapidly cyclized during **1a** biosynthesis, inhibiting potentially harmful interactions with external nucleophiles. Nonenzymatic dipeptidyl cyclization is likely also facilitated by the extraordinarily high nucleophilicity of the Pro-derived nitrogen atom in Pro--Arg dipeptidyls ([@r42]), which may be reduced by the 4-hydroxy group of 4HP. This could explain why 4HP--meArg dipeptidyl intermediates are primarily---but not exclusively---released via R~2~-catalyzed reduction during **1a** biosynthesis, whereas nonenzymatic cyclization completely dominated release of Pro-containing dipeptidyl intermediates even when a functional R~2~ domain was present.

Our results show that very few mutations would have been required during the transition of PpzA-1 to PpzA-2. Interestingly, the A~1~-domain Pro binding, nonmethylated product synthesis, and nonenzymatic dipeptidyl cyclization activities that characterize PpzA-2 proteins were also observed to be reactions that are weakly catalyzed by PpzA-1 proteins. PpzA-2 proteins therefore appear to have evolved through a series of domain subfunctionalizations that cumulatively resulted in an NRPS that efficiently synthesizes **2a**, with our results suggesting this evolutionary cascade could have been triggered by the transposon-mediated R~2~-encoding sequence deletion observed in all *ppzA-2* alleles ([@r14], [@r15], [@r18]). We also showed that further PPZ diversity was generated in the *E. festucae* and *E. bromicola* lineages by recombination-mediated shuffling of functionally divergent sequences between *ppzA-1* and *ppzA-2* alleles. This generated the *ppzA-3* and *ppzA-4* alleles, each of which encodes a protein with novel biosynthetic activity. Due to their modular nature, recombination-vectored domain exchange has long been proposed as a dominant mechanism driving NRPS evolution and diversity, although relatively few examples have been described ([@r43][@r44]--[@r45]). The *ppzA* loci of *Epichloë* spp. represent a remarkably clean example of this process, as even the most divergent alleles share ≥95% DNA sequence identity. Interestingly, *Ebr_ppzA-2* and *Efe_ppzA-2* were also shown to have undergone extensive recombination, yet these alleles remain functionally equivalent to their nonrecombinant *Ety_ppzA-2* counterparts. This suggests that the *E. bromicola* and *E. festucae* lineages may have inherited a nonfunctional *ppzA-2* pseudogene that was repaired through recombination with a functional *ppzA-1* donor. Surprisingly, the equivalent recombination patterns exhibited by *Ebr_ppzA-2*/*Efe_ppzA-2* and *Ebr_ppzA-3*/*Efe_ppzA-3* alleles appear to have arisen after divergence of the *E. bromicola* and *E. festucae* lineages in an example of convergent evolution.

Interestingly, the *ppzA-2*--derived regions of the recombinant *ppzA-2*, *ppzA-3*, and *ppzA-4* alleles exhibit TSP, meaning that the donor *ppzA-2* alleles diverged from *ppzA-1* before emergence of the *E. bromicola*, *E. festucae*, and *E. typhina* lineages. Each of these species also has conspecific strains with functionally distinct *ppzA* alleles, suggesting that the *ppzA* locus is subject to negative frequency-dependent or "balancing" selective pressures that reduce the fitness of the most common allele. The major histocompatibility complex (MHC) in mammals is a well-characterized example of TSP, with balancing selection driven by pathogenic coevolution thought to have prevented fixation of any one MHC allele ([@r46], [@r47]). Analogous balancing selective pressures on the *ppzA* locus could be driven by coevolution of resistance against the dominant PPZ chemotype in target insects, or by displacement of susceptible insect species by resistant competitors. For example, previous experiments have demonstrated that although **1a** exhibits potent feeding deterrent activity against *L. bonariensis* it is not active against several other species ([@r12], [@r48], [@r49]), which could potentially be susceptible to other PPZs. The *N*-methyl group is known to be essential for the bioactivity of **1a** ([@r12]), suggesting that while *N*-methylated PPZ-1,4-diones **2b** and **2c** may exhibit activities similar to **1a**, the nonmethylated PPZ-1,4-diones **2a** and **2d** likely do not. This is supported by the results of Rowan et al. ([@r12]), who coincidentally tested **2a** due to its structural analogy with **1a** and demonstrated that **2a** does not deter feeding by *L. bonariensis*. However, **2a** has previously been shown to be a potent inhibitor of chitinase activity ([@r50], [@r51]) and might thus interfere with insect ecdysis or suppress fungal competitors instead. Future studies into **2a--d** would be useful to determine if these PPZ-1,4-diones exhibit agriculturally relevant bioactivities.

The results presented here demonstrate that nonenzymatic dipeptidyl thioester cyclization can be utilized by NRPSs in vivo for the efficient synthesis of DKP-containing metabolites, meaning that this mechanism should be considered when encountering NRPSs without an obvious termination domain. Further studies of PpzA proteins could reveal if these enzymes exhibit features that facilitate this process, such as the proposed *cis*-peptide-forming C domain. Although reports of allelic neofunctionalization and TSP in fungi are rare, we demonstrate that these processes can generate considerable diversity and suggest that both processes may be more prevalent than currently realized. These processes may be particularly relevant at allelic loci where gene conversion is inhibited by the insertion of large homology-breaking DNA elements such as transposons. TSP and lateral gene transfer can also produce similar phylogenetic patterns, particularly between closely related species, meaning that both hypotheses need to be considered carefully.

Materials and Methods {#s10}
=====================

A comprehensive description of the materials and methods used in this study is available in [*SI Appendix*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental). Homologous recombination was used to generate *E. festucae* ∆*ppzA-2* strains. Constructs for *ppzA* expression in *P. paxilli* were assembled with all *ppzA* variants placed under transcriptional control of the same regulatory sequences from the native *P. paxilli* secondary metabolism gene *paxM*. These constructs were introduced into the *P. paxilli* genome via nontargeted integration, with RT-PCR used to select at least 3 independent transformants expressing each *ppzA* variant. Cultures for metabolite analysis were grown for 6 d under standardized conditions, with substrate feeding performed at 4 and 5 d postinoculation. PPZ metabolites were extracted from lyophilized *P. paxilli* mycelia or *Epichloë*-infected plant material and were analyzed using hydrophilic-interaction chromatography-coupled positive electrospray ionization mass spectroscopy (LCMS).

Data Availability. {#s11}
------------------

DNA sequence data generated during this study have been deposited in the GenBank database under accession numbers MN605951 to MN605962. Raw PPZ concentrations from all LCMS analyses, MS^n^ spectra for all PPZ metabolites, and NMR spectra for **2a** are available in [*SI Appendix*](https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1913080116/-/DCSupplemental).
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